메뉴 건너뛰기




Volumn 8, Issue 1, 2008, Pages 3-4

Management of hyperglycaemia in type 2 diabetes: A clinician's algorithm

Author keywords

[No Author keywords available]

Indexed keywords

ACARBOSE; ANTIDIABETIC AGENT; DIPEPTIDYL PEPTIDASE IV INHIBITOR; EXENDIN 4; GLUCAGON LIKE PEPTIDE 1 DERIVATIVE; GLUCOPHAGE SR; HEMOGLOBIN A1C; INSULIN; MEGLITINIDE; METFORMIN; PIOGLITAZONE; SITAGLIPTIN; SULFONYLUREA; UNCLASSIFIED DRUG;

EID: 41349108059     PISSN: 14746514     EISSN: None     Source Type: Journal    
DOI: 10.1177/14746514080080010101     Document Type: Editorial
Times cited : (1)

References (7)
  • 1
    • 33745780301 scopus 로고    scopus 로고
    • Management of hyperglycaemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy
    • Nathan DM, Buse JB, Davidson MB et al. Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. Diabetologia 2006; 49:1711-21.
    • (2006) Diabetologia , vol.49 , pp. 1711-1721
    • Nathan, D.M.1    Buse, J.B.2    Davidson, M.B.3
  • 2
    • 36649035304 scopus 로고    scopus 로고
    • Management of hyperglycaemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy. Update regarding the thiazolidinediones
    • Nathan DM, Buse JB, Davidson MB et al. Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. Update regarding the thiazolidinediones. Diabetologia 2008;51:8-11.
    • (2008) Diabetologia , vol.51 , pp. 8-11
    • Nathan, D.M.1    Buse, J.B.2    Davidson, M.B.3
  • 3
    • 33748320784 scopus 로고    scopus 로고
    • A consensus algorithm for treating hyperglycaemia in type 2 diabetes
    • Bailey CJ, Day C, Campbell IW. A consensus algorithm for treating hyperglycaemia in type 2 diabetes. Br J Diabetes Vasc Dis 2006; 6:147-8.
    • (2006) Br J Diabetes Vasc Dis , vol.6 , pp. 147-148
    • Bailey, C.J.1    Day, C.2    Campbell, I.W.3
  • 4
    • 35848970300 scopus 로고    scopus 로고
    • Tolerability of prolonged-release metformin (Glucophage® SR) in individuals intolerant to standard metformin. Results from four UK centres
    • Feher MD, Al-Mrayat M, Brake J, Leong K. Tolerability of prolonged-release metformin (Glucophage® SR) in individuals intolerant to standard metformin. Results from four UK centres. Br J Diabetes Vasc Dis 2007;7:225-8.
    • (2007) Br J Diabetes Vasc Dis , vol.7 , pp. 225-228
    • Feher, M.D.1    Al-Mrayat, M.2    Brake, J.3    Leong, K.4
  • 5
    • 33845392184 scopus 로고    scopus 로고
    • New therapies available for the treatment of diabetes
    • Day C. New therapies available for the treatment of diabetes. Eur Diabetes Nursing 2006;3:65-70.
    • (2006) Eur Diabetes Nursing , vol.3 , pp. 65-70
    • Day, C.1
  • 6
    • 34249677406 scopus 로고    scopus 로고
    • Gut hormones, incretin mimetics and gliptins: New understanding and novel therapies in type 2 diabetes
    • Munro N, Levy J. Gut hormones, incretin mimetics and gliptins: New understanding and novel therapies in type 2 diabetes. Primary Care Diabetes 2007;1:103-05.
    • (2007) Primary Care Diabetes , vol.1 , pp. 103-105
    • Munro, N.1    Levy, J.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.